Signature »

Entrada Therapeutics shares owned by Signature

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Signature from 13F filings

Historical chart of Signature investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Signature consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Signature

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.7k 167 10.28
2025-06-30 $356 53 6.72

More positions owned by Signature

Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr Core S&p Us Vlu (IUSV)
Vanguard Malvern Fds Core Bd Etf (VCRB)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr National Mun Etf (MUB)
Vanguard Index Fds Large Cap Etf (VV)
Microsoft Corporation (MSFT)
Vanguard Index Fds Growth Etf (VUG)

View all positions for Signature

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
MPM Asset Management
5AM Venture Management
BlackRock
TCG Crossover Management
Vanguard Group
Wellington Management Company
Millennium Management
StepStone
Geode Capital Management
State Street Corporation
Jacobs Levy Equity Management
Citadel Advisors
Acadian Asset Management
Dimensional Fund Advisors

View all funds holding Entrada Therapeutics